Trials / Completed
CompletedNCT03118778
Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population
Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population: A Descriptive Retrospective Observational Study Using Database
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90,895 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a descriptive retrospective database analysis study in using database. All patients with a physician PPI prescription will be selected to estimate the PPI inappropriate use.
Detailed description
Study primary objective is to identify the inappropriate use of PPI (overall, outpatient \& inpatient).
Conditions
Timeline
- Start date
- 2017-04-28
- Primary completion
- 2017-07-10
- Completion
- 2017-07-10
- First posted
- 2017-04-18
- Last updated
- 2018-07-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03118778. Inclusion in this directory is not an endorsement.